Line Broch

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Differences in Income Growth Between People With Multiple Sclerosis and Controls: A Norwegian Cohort Study.

Differences in Income Growth Between People With Multiple Sclerosis and Controls: A Norwegian Cohort Study.

Journal: European journal of neurology

Published: December 19, 2025

Reduced childbirth rates in multiple sclerosis from the prodromal phase: Evidence from a population-based cohort study.

Reduced childbirth rates in multiple sclerosis from the prodromal phase: Evidence from a population-based cohort study.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: February 17, 2025

The influence of menopause on multiple sclerosis.

The influence of menopause on multiple sclerosis.

Journal: European journal of neurology

Published: March 07, 2024

"No association between disease modifying treatment and fatigue in multiple sclerosis".

"No association between disease modifying treatment and fatigue in multiple sclerosis".

Journal: Multiple sclerosis and related disorders

Published: March 06, 2023

Rebaseline no evidence of disease activity (NEDA-3) as a predictor of long-term disease course in a Norwegian multiple sclerosis population.

Rebaseline no evidence of disease activity (NEDA-3) as a predictor of long-term disease course in a Norwegian multiple sclerosis population.

Journal: Frontiers in neurology

Published: September 01, 2022

Fatigue in multiple sclerosis is associated with socioeconomic factors.

Fatigue in multiple sclerosis is associated with socioeconomic factors.

Journal: Multiple sclerosis and related disorders

Published: April 20, 2022

The influence of socioeconomic factors on access to disease modifying treatment in a Norwegian multiple sclerosis cohort.

The influence of socioeconomic factors on access to disease modifying treatment in a Norwegian multiple sclerosis cohort.

Journal: Multiple sclerosis and related disorders

Published: January 19, 2022

Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry.

Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry.

Journal: Frontiers in neurology

Published: April 09, 2021

No significant differences in absenteeism or academic achievements in a Norwegian multiple sclerosis case control study.

No significant differences in absenteeism or academic achievements in a Norwegian multiple sclerosis case control study.

Journal: Multiple sclerosis and related disorders

Published: March 29, 2021

Maternal education has significant influence on progression in multiple sclerosis.

Maternal education has significant influence on progression in multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: March 05, 2021

High prevalence of fatigue in contemporary patients with multiple sclerosis.

High prevalence of fatigue in contemporary patients with multiple sclerosis.

Journal: Multiple sclerosis journal - experimental, translational and clinical

Published: February 11, 2021

The course of multiple sclerosis rewritten: a Norwegian population-based study on disease demographics and progression.

The course of multiple sclerosis rewritten: a Norwegian population-based study on disease demographics and progression.

Journal: Journal of neurology

Published: August 03, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026